Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Participants Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending d…

Type 1 Diabetes MellitusT1DT1DM+7 more

COUR Pharmaceutical Development Company, Inc.NCT06783309